Zymeworks Inc ZYME

NYS: ZYME | ISIN: CA98985W1023 14/11/2024

16,26 USD (-5,52%)

(-5,52%) 14/11/2024

Grafiek Zymeworks Inc

Grafiek Zymeworks Inc

1 dag1d -5,52%
1 week1w -2,22%
1 maand1m 16,77%
3 maanden3m 54,86%
6 maanden6m 77,70%
1 jaar1j 110,89%
5 jaar5j -55,01%

Zymeworks Inc in het nieuws

Toon enkel gratis nieuws

19 januari 2023 · Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating Zanidatamab in HER2-Expressing Metastatic Gastroesophageal Adenocarcinoma · Persbericht

19 oktober 2022 · Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific Antibody · Persbericht

19 mei 2022 · All Blue Capital Expands Its Leadership Team To Support Proposed Acquisition Of Zymeworks Inc. · Persbericht

3 mei 2022 · All Blue Capital Announces Leadership To Support Proposed Acquisition Of Zymeworks, Inc. · Persbericht

Profiel Zymeworks Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe